GSK, Teva Can't Put Brakes On Pay-For-Delay Challenge
GlaxoSmithKline PLC and Teva Pharmaceutical Industries Ltd. on Tuesday failed to pause class action allegations that they conspired to keep a generic drug off the market, after a New Jersey federal...To view the full article, register now.
Already a subscriber? Click here to view full article